首页 > 最新文献

Saudi Journal of Gastroenterology最新文献

英文 中文
Correlation between physician- and patient-directed disease assessments in ulcerative colitis patients from Saudi Arabia and Kuwait: Data from ICONIC. 沙特阿拉伯和科威特溃疡性结肠炎患者中医生和患者指导的疾病评估之间的相关性:来自ICONIC的数据
IF 2.7 4区 医学 Q2 Medicine Pub Date : 2023-11-01 DOI: 10.4103/sjg.sjg_92_23
Othman Al Harbi, Salem Owayed, Yousif Qari, Mahmoud Mosli, Ali Anwar, Alaa Masri, Mohamed Gouda, Ahmed Alfadhli

Background: The aim of the observational, prospective study was to validate a novel, nonverbal assessment tool for perceived disease burden-Pictorial Representation of Illness and Self-Measure (PRISM)-in ulcerative colitis (UC) against established patient health questionnaires. The cumulative burden of patients recently diagnosed (<3 years) with UC was also evaluated.

Methods: "ICONIC" - Understanding the impact of ulcerative colitis and its associated disease burden on patients - was a noninterventional, multicountry, multicenter study performed in a 2-year follow-up format in adult patients with recently diagnosed UC in 33 countries, regardless of disease severity or treatment. Data collection consisted of five visits, scheduled at approximately 6-month intervals. For the current analysis, patient data from Saudi Arabia and Kuwait were evaluated. The collected data comprised demographics, disease-related data, UC treatment, and healthcare resources, as well as physician- and patient-assessed quality-of-life and disease burden questionnaires. Correlations between selected questionnaire scores were performed using Spearman's rho.

Results: Disease severity at baseline and throughout the study was slightly less favorable in this country analysis compared with the global study cohort. Disease burden was assessed by PRISM and improved within 24 months.

Conclusions: The detected moderate correlation between PRISM and other assessment methods supports the validity of PRISM. Differences in perceptions of UC-related burden between physician and patient may reflect to some degree insufficient patient-physician communication.

背景:这项观察性、前瞻性研究的目的是验证溃疡性结肠炎(UC)患者感知疾病负担的一种新的非语言评估工具——疾病图像表征和自我测量(PRISM)。方法:“ICONIC”——了解溃疡性结肠炎及其相关疾病负担对患者的影响——是一项非介入性、多国家、多中心的研究,在33个国家对最近诊断为UC的成年患者进行了为期2年的随访,无论疾病严重程度或治疗方式如何。数据收集包括5次访问,每6个月进行一次。对于当前的分析,来自沙特阿拉伯和科威特的患者数据被评估。收集的数据包括人口统计数据、疾病相关数据、UC治疗和医疗资源,以及医生和患者评估的生活质量和疾病负担问卷。所选问卷得分之间的相关性使用Spearman's rho进行。结果:与全球研究队列相比,该国家分析在基线和整个研究期间的疾病严重程度稍差。采用PRISM评估疾病负担,并在24个月内改善。结论:PRISM与其他评估方法之间存在中度相关性,支持PRISM的有效性。医患对uc相关负担认知的差异,可能在一定程度上反映了医患沟通的不足。
{"title":"Correlation between physician- and patient-directed disease assessments in ulcerative colitis patients from Saudi Arabia and Kuwait: Data from ICONIC.","authors":"Othman Al Harbi, Salem Owayed, Yousif Qari, Mahmoud Mosli, Ali Anwar, Alaa Masri, Mohamed Gouda, Ahmed Alfadhli","doi":"10.4103/sjg.sjg_92_23","DOIUrl":"10.4103/sjg.sjg_92_23","url":null,"abstract":"<p><strong>Background: </strong>The aim of the observational, prospective study was to validate a novel, nonverbal assessment tool for perceived disease burden-Pictorial Representation of Illness and Self-Measure (PRISM)-in ulcerative colitis (UC) against established patient health questionnaires. The cumulative burden of patients recently diagnosed (<3 years) with UC was also evaluated.</p><p><strong>Methods: </strong>\"ICONIC\" - Understanding the impact of ulcerative colitis and its associated disease burden on patients - was a noninterventional, multicountry, multicenter study performed in a 2-year follow-up format in adult patients with recently diagnosed UC in 33 countries, regardless of disease severity or treatment. Data collection consisted of five visits, scheduled at approximately 6-month intervals. For the current analysis, patient data from Saudi Arabia and Kuwait were evaluated. The collected data comprised demographics, disease-related data, UC treatment, and healthcare resources, as well as physician- and patient-assessed quality-of-life and disease burden questionnaires. Correlations between selected questionnaire scores were performed using Spearman's rho.</p><p><strong>Results: </strong>Disease severity at baseline and throughout the study was slightly less favorable in this country analysis compared with the global study cohort. Disease burden was assessed by PRISM and improved within 24 months.</p><p><strong>Conclusions: </strong>The detected moderate correlation between PRISM and other assessment methods supports the validity of PRISM. Differences in perceptions of UC-related burden between physician and patient may reflect to some degree insufficient patient-physician communication.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10081874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does percutaneous cholecystostomy affect prognosis of patients with acute cholecystitis that are unresponsive to conservative treatment? 经皮胆囊造口术是否会影响保守治疗无效的急性胆囊炎患者的预后?
IF 2.7 4区 医学 Q2 Medicine Pub Date : 2023-11-01 DOI: 10.4103/sjg.sjg_87_23
Danny Hazan, Eyal Leibovitz, Muhamad Jazmawi, Mordechai Shimonov

Background: Percutaneous cholecystostomy (PC) can be used as bridging or definitive therapy in some cases of acute cholecystitis. We aimed to compare hospital stay and survival of patients that underwent PC insertion because of acute calculus cholecystitis (ACC) compared to those who did not.

Methods: This is a retrospective study in which patients with gangrenous cholecystitis and perforation were excluded. Regression models were used to evaluate the influence of PC on mortality and hospital stay.

Results: Six hundred and eighty-three patients were admitted because of ACC, and 50 patients were referred to PC. Indication for PC insertion were high disease severity index (DSI, 8 pts) and failure of conservative treatment with total disease duration >7 days (42 pts). Those who underwent PC were older (76.0 ± 12.4 vs. 60.8 ± 19.2, P < 0.001); PC was associated with longer hospital stay (12.8 vs. 6.5 days) and higher one-year mortality (20% vs. 4.9%, P < 0.001). Among patients with non-severe disease severity index (DSI), PC was associated with longer length of hospital stay and higher one-year mortality compared to patients treated conservatively (9.9 ± 0.6 vs. 6.0 ± 0.2 days, and 16.7% vs. 4.0%, respectively, P < 0.001 for both). For patients with severe DSI, PC was associated with similar length of hospital stay and one-year mortality compared to similar patients treated conservatively (16.1 ± 8.1 vs. 18.4 ± 4.0 days, and 37.5% vs. 22.6%, respectively, P = 0.802 and P = 0.389, respectively).

Conclusions: In patients with mild-moderate DSI unresponsive to conservative treatment, PC may be associated with deteriorated prognosis compared to conservative treatment. The decision to insert PC in patients unresponsive to conservative therapy even with disease duration >7 days must be re-evaluated.

背景:经皮胆囊造口术(PC)可作为急性胆囊炎的桥接或最终治疗。我们的目的是比较因急性结石性胆囊炎(ACC)而接受PC插入的患者与未接受PC插入的患者的住院时间和生存率。方法:这是一项回顾性研究,排除坏疽性胆囊炎和穿孔。采用回归模型评估PC对死亡率和住院时间的影响。结果:683例患者因ACC入院,50例患者转诊为PC。植入术指征为疾病严重程度指数高(DSI, 8分),保守治疗失败,总病程bb7天(42分)。接受PC的患者年龄较大(76.0±12.4比60.8±19.2,P < 0.001);PC与较长的住院时间(12.8天对6.5天)和较高的1年死亡率相关(20%对4.9%,P < 0.001)。在非严重疾病严重程度指数(DSI)的患者中,与保守治疗的患者相比,PC与更长的住院时间和更高的一年死亡率相关(分别为9.9±0.6天对6.0±0.2天,16.7%对4.0%,P均< 0.001)。对于严重DSI患者,与保守治疗的类似患者相比,PC与相似的住院时间和一年死亡率相关(分别为16.1±8.1天对18.4±4.0天,37.5%对22.6%,P = 0.802和P = 0.389)。结论:在对保守治疗无反应的轻中度DSI患者中,与保守治疗相比,PC可能与预后恶化有关。对于对保守治疗无反应的患者,即使病程持续7天,也必须重新评估植入PC的决定。
{"title":"Does percutaneous cholecystostomy affect prognosis of patients with acute cholecystitis that are unresponsive to conservative treatment?","authors":"Danny Hazan, Eyal Leibovitz, Muhamad Jazmawi, Mordechai Shimonov","doi":"10.4103/sjg.sjg_87_23","DOIUrl":"10.4103/sjg.sjg_87_23","url":null,"abstract":"<p><strong>Background: </strong>Percutaneous cholecystostomy (PC) can be used as bridging or definitive therapy in some cases of acute cholecystitis. We aimed to compare hospital stay and survival of patients that underwent PC insertion because of acute calculus cholecystitis (ACC) compared to those who did not.</p><p><strong>Methods: </strong>This is a retrospective study in which patients with gangrenous cholecystitis and perforation were excluded. Regression models were used to evaluate the influence of PC on mortality and hospital stay.</p><p><strong>Results: </strong>Six hundred and eighty-three patients were admitted because of ACC, and 50 patients were referred to PC. Indication for PC insertion were high disease severity index (DSI, 8 pts) and failure of conservative treatment with total disease duration >7 days (42 pts). Those who underwent PC were older (76.0 ± 12.4 vs. 60.8 ± 19.2, P < 0.001); PC was associated with longer hospital stay (12.8 vs. 6.5 days) and higher one-year mortality (20% vs. 4.9%, P < 0.001). Among patients with non-severe disease severity index (DSI), PC was associated with longer length of hospital stay and higher one-year mortality compared to patients treated conservatively (9.9 ± 0.6 vs. 6.0 ± 0.2 days, and 16.7% vs. 4.0%, respectively, P < 0.001 for both). For patients with severe DSI, PC was associated with similar length of hospital stay and one-year mortality compared to similar patients treated conservatively (16.1 ± 8.1 vs. 18.4 ± 4.0 days, and 37.5% vs. 22.6%, respectively, P = 0.802 and P = 0.389, respectively).</p><p><strong>Conclusions: </strong>In patients with mild-moderate DSI unresponsive to conservative treatment, PC may be associated with deteriorated prognosis compared to conservative treatment. The decision to insert PC in patients unresponsive to conservative therapy even with disease duration >7 days must be re-evaluated.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754375/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10136072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unlocking the path to efficient H. pylori eradication: Embracing potassium-competitive acid blockers (P-CABs). 打开有效根除幽门螺杆菌的途径:拥抱钾竞争酸阻滞剂(p - cab)。
IF 2.7 4区 医学 Q2 Medicine Pub Date : 2023-11-01 DOI: 10.4103/sjg.sjg_297_23
Thomas J Borody, John Ng, Sibasish Dolai
{"title":"Unlocking the path to efficient <i>H. pylori</i> eradication: Embracing potassium-competitive acid blockers (P-CABs).","authors":"Thomas J Borody, John Ng, Sibasish Dolai","doi":"10.4103/sjg.sjg_297_23","DOIUrl":"10.4103/sjg.sjg_297_23","url":null,"abstract":"","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10232048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disease patterns among Saudi children undergoing colonoscopy for lower gastrointestinal bleeding: Single tertiary care center experience. 下消化道出血接受结肠镜检查的沙特儿童的疾病模式:单一三级保健中心经验。
IF 2.7 4区 医学 Q2 Medicine Pub Date : 2023-11-01 DOI: 10.4103/sjg.sjg_130_23
Sami Alrashidi, Tarig AlAmery, Abdullah Alshanbary, Eman Aljohani, Salman M Bashir, Bader Alsaleem, Ali Asery, Abdulrahman Al-Hussaini

Background: : The yield of colonoscopy in cases presenting with lower gastrointestinal bleeding (LGIB) in previously published studies varies according to several factors, including endoscopic skills, histopathological experience, and pattern of colonic pathology in different countries. The local literature is limited to a single small 20-year-old study. Our objective was to provide updated data on the diagnostic yield of colonoscopy in Saudi children with LGIB in Saudi Arabia.

Methods: : This was a retrospective analysis of pediatric patients (0-14 years of age) who underwent colonoscopy for LGIB at the King Fahad Medical City (KFMC), from 2008 to 2018. LGIB was defined as fresh or dark blood per rectum.

Results: : During the study period, 175 children underwent colonoscopy for LGIB (99 males, mean age 7.05 ± 3.81 years), which constituted 53.5% of indications for colonoscopy procedures (n = 327) in our center. The terminal ileum was intubated in 81% of the procedures. Overall, inflammatory bowel disease (IBD) was the most commonly identified cause of LGIB (32% ) followed by colonic lymphonodular hyperplasia (CLNH) in 17% and juvenile polyp and rectal mucosal prolapse syndrome (RMPS), 11% each. On sub-analysis, cow's milk protein allergy (CMPA) and CLNH were the most common causes in infants and toddlers, 35% each; IBD (26.5%) and polyps (22.4%) in young children (2-6 years), and IBD (36%), CLNH (14.9%) and RMPS (14%) in older children (6-14 years). In comparing the IBD to the non-IBD group, IBD patients were older (mean 8.37 vs. 6.46 years, P = 0.002) and more likely to have diarrhea, weight loss, high erythrocyte sedimentation rate, anemia, and hypoalbuminemia (odds ratio 24, 11, 10.7, 6.5, and 4, respectively). Colonoscopy had a sensitivity of 97%, specificity of 100%, positive predictive value of 100%, negative predictive value of 81.4%, and accuracy of 97% in diagnosing LGIB.

Conclusion: : Colonoscopy is an effective diagnostic tool in children with LGIB with a high diagnostic yield. Besides IBD, CLNH and RMPS are two other important pathologic entities that need to be considered in a child with LGIB.

背景:在先前发表的研究中,下消化道出血(LGIB)病例的结肠镜检查率因几个因素而异,包括内镜技术、组织病理学经验和不同国家的结肠病理模式。当地文献仅限于一项20年的小型研究。我们的目的是为沙特阿拉伯患有LGIB的儿童提供结肠镜检查诊断率的最新数据。方法:回顾性分析2008年至2018年在法赫德国王医疗城(KFMC)接受LGIB结肠镜检查的儿童患者(0-14岁)。LGIB定义为每个直肠有新鲜或深色血液。结果:研究期间,175名儿童接受了LGIB结肠镜检查,其中男性99名,平均年龄7.05±3.81岁,占本中心结肠镜检查适应症的53.5% (n = 327)。在81%的手术中,回肠末段插管。总体而言,炎症性肠病(IBD)是LGIB最常见的病因(32%),其次是结肠淋巴结节增生(CLNH)(17%)和青少年息肉和直肠粘膜脱垂综合征(RMPS),各占11%。在亚分析中,牛奶蛋白过敏(CMPA)和CLNH是婴幼儿中最常见的原因,各占35%;幼儿(2-6岁)IBD(26.5%)和息肉(22.4%),较大儿童(6-14岁)IBD(36%)、CLNH(14.9%)和RMPS(14%)。将IBD组与非IBD组进行比较,IBD患者年龄较大(平均8.37岁vs 6.46岁,P = 0.002),更容易出现腹泻、体重减轻、高红细胞沉降率、贫血和低白蛋白血症(优势比分别为24、11、10.7、6.5和4)。结肠镜诊断LGIB的敏感性为97%,特异性为100%,阳性预测值为100%,阴性预测值为81.4%,准确率为97%。结论:结肠镜检查是诊断儿童LGIB的有效工具,诊断率高。除了IBD, CLNH和RMPS是LGIB患儿需要考虑的另外两个重要的病理实体。
{"title":"Disease patterns among Saudi children undergoing colonoscopy for lower gastrointestinal bleeding: Single tertiary care center experience.","authors":"Sami Alrashidi, Tarig AlAmery, Abdullah Alshanbary, Eman Aljohani, Salman M Bashir, Bader Alsaleem, Ali Asery, Abdulrahman Al-Hussaini","doi":"10.4103/sjg.sjg_130_23","DOIUrl":"10.4103/sjg.sjg_130_23","url":null,"abstract":"<p><strong>Background: </strong>: The yield of colonoscopy in cases presenting with lower gastrointestinal bleeding (LGIB) in previously published studies varies according to several factors, including endoscopic skills, histopathological experience, and pattern of colonic pathology in different countries. The local literature is limited to a single small 20-year-old study. Our objective was to provide updated data on the diagnostic yield of colonoscopy in Saudi children with LGIB in Saudi Arabia.</p><p><strong>Methods: </strong>: This was a retrospective analysis of pediatric patients (0-14 years of age) who underwent colonoscopy for LGIB at the King Fahad Medical City (KFMC), from 2008 to 2018. LGIB was defined as fresh or dark blood per rectum.</p><p><strong>Results: </strong>: During the study period, 175 children underwent colonoscopy for LGIB (99 males, mean age 7.05 ± 3.81 years), which constituted 53.5% of indications for colonoscopy procedures (n = 327) in our center. The terminal ileum was intubated in 81% of the procedures. Overall, inflammatory bowel disease (IBD) was the most commonly identified cause of LGIB (32% ) followed by colonic lymphonodular hyperplasia (CLNH) in 17% and juvenile polyp and rectal mucosal prolapse syndrome (RMPS), 11% each. On sub-analysis, cow's milk protein allergy (CMPA) and CLNH were the most common causes in infants and toddlers, 35% each; IBD (26.5%) and polyps (22.4%) in young children (2-6 years), and IBD (36%), CLNH (14.9%) and RMPS (14%) in older children (6-14 years). In comparing the IBD to the non-IBD group, IBD patients were older (mean 8.37 vs. 6.46 years, P = 0.002) and more likely to have diarrhea, weight loss, high erythrocyte sedimentation rate, anemia, and hypoalbuminemia (odds ratio 24, 11, 10.7, 6.5, and 4, respectively). Colonoscopy had a sensitivity of 97%, specificity of 100%, positive predictive value of 100%, negative predictive value of 81.4%, and accuracy of 97% in diagnosing LGIB.</p><p><strong>Conclusion: </strong>: Colonoscopy is an effective diagnostic tool in children with LGIB with a high diagnostic yield. Besides IBD, CLNH and RMPS are two other important pathologic entities that need to be considered in a child with LGIB.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10598254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations. 幽门螺杆菌感染管理实践指南:沙特幽门螺杆菌工作组的建议。
IF 2.7 4区 医学 Q2 Medicine Pub Date : 2023-11-01 DOI: 10.4103/sjg.sjg_288_22
Fahad Alsohaibani, Musthafa Peedikayil, Abdulaziz Alshahrani, Ali Somily, Raed Alsulaiman, Nahla Azzam, Majid Almadi

The eradication rates for Helicobacter pylori globally are decreasing with a dramatic increase in the prevalence of antibiotic resistant bacteria all over the world, including Saudi Arabia. There is no current consensus on the management of H. pylori in Saudi Arabia. The Saudi Gastroenterology Association developed these practice guidelines after reviewing the local and regional studies on the management of H. pylori. The aim was to establish recommendations to guide healthcare providers in managing H. pylori in Saudi Arabia. Experts in the areas of H. pylori management and microbiology were invited to write these guidelines. A literature search was performed, and all authors participated in writing and reviewing the guidelines. In addition, international guidelines and consensus reports were reviewed to bridge the gap in knowledge when local and regional data were unavailable. There is limited local data on treatment of H. pylori. The rate of clarithromycin and metronidazole resistance is high; therefore, standard triple therapy for 10-14 days is no longer recommended in the treatment of H. pylori unless antimicrobial susceptibility testing was performed. Based on the available data, bismuth quadruple therapy for 10-14 days is considered the best first-line and second-line therapy. Culture and antimicrobial susceptibility testing should be considered following two treatment failures. These recommendations are intended to provide the most relevant evidence-based guidelines for the management of H. pylori infection in Saudi Arabia. The working group recommends further studies to explore more therapeutic options to eradicate H. pylori.

全球幽门螺杆菌的根除率正在下降,包括沙特阿拉伯在内的世界各地抗生素耐药细菌的流行率急剧上升。目前在沙特阿拉伯对幽门螺旋杆菌的管理尚无共识。沙特胃肠病学协会在审查了当地和区域对幽门螺杆菌管理的研究后制定了这些实践指南。目的是建立建议,指导卫生保健提供者管理幽门螺旋杆菌在沙特阿拉伯。幽门螺杆菌管理和微生物学领域的专家被邀请撰写这些指南。进行文献检索,所有作者参与编写和审查指南。此外,还审查了国际准则和协商一致报告,以便在没有当地和区域数据的情况下弥补知识上的差距。当地关于幽门螺杆菌治疗的资料有限。克拉霉素、甲硝唑耐药率高;因此,标准的三联疗法10-14天不再推荐用于治疗幽门螺杆菌,除非进行抗菌药敏试验。根据现有资料,10-14天的铋四联治疗被认为是最好的一线和二线治疗。在两次治疗失败后应考虑进行培养和抗菌药物敏感性试验。这些建议旨在为沙特阿拉伯幽门螺杆菌感染的管理提供最相关的循证指南。工作组建议进一步研究以探索根除幽门螺杆菌的更多治疗方案。
{"title":"Practice guidelines for the management of <i>Helicobacter pylori</i> infection: The Saudi <i>H. pylori</i> Working Group recommendations.","authors":"Fahad Alsohaibani, Musthafa Peedikayil, Abdulaziz Alshahrani, Ali Somily, Raed Alsulaiman, Nahla Azzam, Majid Almadi","doi":"10.4103/sjg.sjg_288_22","DOIUrl":"10.4103/sjg.sjg_288_22","url":null,"abstract":"<p><p>The eradication rates for Helicobacter pylori globally are decreasing with a dramatic increase in the prevalence of antibiotic resistant bacteria all over the world, including Saudi Arabia. There is no current consensus on the management of H. pylori in Saudi Arabia. The Saudi Gastroenterology Association developed these practice guidelines after reviewing the local and regional studies on the management of H. pylori. The aim was to establish recommendations to guide healthcare providers in managing H. pylori in Saudi Arabia. Experts in the areas of H. pylori management and microbiology were invited to write these guidelines. A literature search was performed, and all authors participated in writing and reviewing the guidelines. In addition, international guidelines and consensus reports were reviewed to bridge the gap in knowledge when local and regional data were unavailable. There is limited local data on treatment of H. pylori. The rate of clarithromycin and metronidazole resistance is high; therefore, standard triple therapy for 10-14 days is no longer recommended in the treatment of H. pylori unless antimicrobial susceptibility testing was performed. Based on the available data, bismuth quadruple therapy for 10-14 days is considered the best first-line and second-line therapy. Culture and antimicrobial susceptibility testing should be considered following two treatment failures. These recommendations are intended to provide the most relevant evidence-based guidelines for the management of H. pylori infection in Saudi Arabia. The working group recommends further studies to explore more therapeutic options to eradicate H. pylori.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33493362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Comparison of KRAS gene in circulating tumor DNA levels vs histological grading of colorectal cancer patients through liquid biopsy. 结直肠癌患者循环肿瘤DNA中KRAS基因水平与液体活检组织学分级的比较
IF 2.7 4区 医学 Q2 Medicine Pub Date : 2023-11-01 DOI: 10.4103/sjg.sjg_85_23
Hafiz Syed Mohammad Osama Jafri, Shamim Mushtaq, Saeeda Baig, Afreen Bhatty, Sabra Siraj

Background: To determine KRAS gene in circulating tumor DNA in comparison with histological grading through liquid biopsy in colorectal cancer patients.

Methods: This dual-centered cross-sectional study included 73 diagnosed patients of colorectal cancer at different grading levels [Grade I, well differentiated (n = 7, 9.5%); Grade II, moderately differentiated (n = 14,18.9%); and Grade III, poorly differentiated (n = 52, 70%)]. Blood was collected, and plasma was separated. ctDNA was extracted, using magnetic bead-based technique (MagMAX Cell-Free DNA kit). KRAS gene was quantified through qPCR. STRING database was used to find KRAS interactomes.

Results: Mean threshold cycle (CT value) of KRAS gene in Grade III samples showed significantly higher (P = 0.001) levels of ctDNA (2.7 ± 1.14) compared with Grade II and Grade I (3.1 ± 0.68, 2.3 ± 0.60), respectively. Grading characterization showed that rectal cancer (n = 22, 42.3%) with Grade III (68.8%) was more prevalent than colon and sigmoid cancer (n = 19, 36.5%, n = 11, 21%, respectively). STRING database showed 10 functional genes interacting with KRAS expressed as gene/proteins.

Conclusion: Liquid biopsy can be used to detect ctDNA in plasma of CRC patients and enabled to detect the KRAS gene by qPCR. The technique being less invasive and cost-effective is convenient for multiple biopsies in different cancers.

背景:通过液体活检检测结直肠癌患者循环肿瘤DNA中的KRAS基因并与组织学分级进行比较。方法:本双中心横断面研究纳入73例不同分级的结直肠癌确诊患者[I级,高分化(n = 7, 9.5%);II级,中度分化(n = 14,18.9%);III级,低分化(n = 52,70%)]。采集了血液,分离了血浆。利用磁珠技术(MagMAX Cell-Free DNA试剂盒)提取ctDNA。采用qPCR方法对KRAS基因进行定量分析。使用STRING数据库查找KRAS交互组。结果:三级患者KRAS基因平均阈值(CT值)ctDNA水平(2.7±1.14)明显高于二级患者(3.1±0.68)、一级患者(2.3±0.60)(P = 0.001)。分级特征显示,III级直肠癌(n = 22,42.3%)(68.8%)比结肠癌和乙状结肠癌(n = 19,36.5%, n = 11,21%)更为普遍。STRING数据库显示10个与KRAS相互作用的功能基因以基因/蛋白的形式表达。结论:液体活检可检测CRC患者血浆中ctDNA, qPCR可检测KRAS基因。该技术侵入性小,成本效益高,便于对不同癌症进行多次活检。
{"title":"Comparison of KRAS gene in circulating tumor DNA levels vs histological grading of colorectal cancer patients through liquid biopsy.","authors":"Hafiz Syed Mohammad Osama Jafri, Shamim Mushtaq, Saeeda Baig, Afreen Bhatty, Sabra Siraj","doi":"10.4103/sjg.sjg_85_23","DOIUrl":"10.4103/sjg.sjg_85_23","url":null,"abstract":"<p><strong>Background: </strong>To determine KRAS gene in circulating tumor DNA in comparison with histological grading through liquid biopsy in colorectal cancer patients.</p><p><strong>Methods: </strong>This dual-centered cross-sectional study included 73 diagnosed patients of colorectal cancer at different grading levels [Grade I, well differentiated (n = 7, 9.5%); Grade II, moderately differentiated (n = 14,18.9%); and Grade III, poorly differentiated (n = 52, 70%)]. Blood was collected, and plasma was separated. ctDNA was extracted, using magnetic bead-based technique (MagMAX Cell-Free DNA kit). KRAS gene was quantified through qPCR. STRING database was used to find KRAS interactomes.</p><p><strong>Results: </strong>Mean threshold cycle (CT value) of KRAS gene in Grade III samples showed significantly higher (P = 0.001) levels of ctDNA (2.7 ± 1.14) compared with Grade II and Grade I (3.1 ± 0.68, 2.3 ± 0.60), respectively. Grading characterization showed that rectal cancer (n = 22, 42.3%) with Grade III (68.8%) was more prevalent than colon and sigmoid cancer (n = 19, 36.5%, n = 11, 21%, respectively). STRING database showed 10 functional genes interacting with KRAS expressed as gene/proteins.</p><p><strong>Conclusion: </strong>Liquid biopsy can be used to detect ctDNA in plasma of CRC patients and enabled to detect the KRAS gene by qPCR. The technique being less invasive and cost-effective is convenient for multiple biopsies in different cancers.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10029540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the risk of future gastrointestinal surgery in Crohn’s disease with stricture 克罗恩病合并狭窄患者未来胃肠手术的风险分析
4区 医学 Q2 Medicine Pub Date : 2023-10-25 DOI: 10.4103/sjg.sjg_256_23
Wen Zeng, Yong Chen, Bolong Yin, Xue Wen, Jian Xiao, Lian Luo, Haiyuan Tang, He Zheng
Abstract Background: Stricture in patients with Crohn’s disease (CD) carries a high risk of CD-related surgery in the course of the disease. The aim of this study was to assess the rate of occurrence of CD-related surgery and to determine baseline risk factors predicting subsequent surgery in this patient group. Methods: Patients registered with stricturing CD were included. All baseline and follow-up data were collected retrospectively. Patients attended the clinic for follow-up at week 14 to assess their response to infliximab (IFX). CD-related surgery was the observational endpoint. Univariate and multivariate Cox regression analyses were used. Results: A total of 123 patients with stricturing CD were included in this study. The cumulative risk of CD-related surgery for years 1–5 after diagnosis was 18.0%, 26.7%, 32.6%, 40.7%, and 46.4%, respectively. Prior gastrointestinal (GI) surgery, low body mass index (BMI), and high platelet count might be risk factors for future CD-related surgery. With 97 participants treated by IFX, prior GI surgery and primary non-response (PNR) to IFX correlated with future CD-related surgery. Conclusion: Prior GI surgery, BMI, and platelet counts were related to future CD-related surgery. Patients who were PNR to IFX had a higher risk of CD-related surgery in the future.
背景:克罗恩病(CD)患者的狭窄在病程中具有较高的CD相关手术风险。本研究的目的是评估该患者组cd相关手术的发生率,并确定预测后续手术的基线危险因素。方法:纳入登记的狭窄性CD患者。所有基线和随访数据回顾性收集。患者在第14周到诊所进行随访,以评估他们对英夫利昔单抗(IFX)的反应。cd相关手术是观察终点。采用单因素和多因素Cox回归分析。结果:本研究共纳入123例狭窄性CD患者。诊断后1-5年cd相关手术的累积风险分别为18.0%、26.7%、32.6%、40.7%和46.4%。既往胃肠道(GI)手术,低体重指数(BMI)和高血小板计数可能是未来cd相关手术的危险因素。在97名接受IFX治疗的参与者中,先前的胃肠道手术和对IFX的原发性无反应(PNR)与未来的cd相关手术相关。结论:既往GI手术、BMI和血小板计数与未来cd相关手术相关。PNR至IFX的患者在未来发生cd相关手术的风险更高。
{"title":"Analysis of the risk of future gastrointestinal surgery in Crohn’s disease with stricture","authors":"Wen Zeng, Yong Chen, Bolong Yin, Xue Wen, Jian Xiao, Lian Luo, Haiyuan Tang, He Zheng","doi":"10.4103/sjg.sjg_256_23","DOIUrl":"https://doi.org/10.4103/sjg.sjg_256_23","url":null,"abstract":"Abstract Background: Stricture in patients with Crohn’s disease (CD) carries a high risk of CD-related surgery in the course of the disease. The aim of this study was to assess the rate of occurrence of CD-related surgery and to determine baseline risk factors predicting subsequent surgery in this patient group. Methods: Patients registered with stricturing CD were included. All baseline and follow-up data were collected retrospectively. Patients attended the clinic for follow-up at week 14 to assess their response to infliximab (IFX). CD-related surgery was the observational endpoint. Univariate and multivariate Cox regression analyses were used. Results: A total of 123 patients with stricturing CD were included in this study. The cumulative risk of CD-related surgery for years 1–5 after diagnosis was 18.0%, 26.7%, 32.6%, 40.7%, and 46.4%, respectively. Prior gastrointestinal (GI) surgery, low body mass index (BMI), and high platelet count might be risk factors for future CD-related surgery. With 97 participants treated by IFX, prior GI surgery and primary non-response (PNR) to IFX correlated with future CD-related surgery. Conclusion: Prior GI surgery, BMI, and platelet counts were related to future CD-related surgery. Patients who were PNR to IFX had a higher risk of CD-related surgery in the future.","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135113828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of survival among patients with chronic hepatitis C at a tertiary care center in Oman 阿曼三级保健中心慢性丙型肝炎患者的生存预测因素
4区 医学 Q2 Medicine Pub Date : 2023-09-20 DOI: 10.4103/sjg.sjg_201_23
Halima H. Al-Shuaili, Said A. Al-Busafi, Khalid Al-Naamani, Zakariya Al-Naamani
Abstract Background: Chronic hepatitis C (CHC) is a leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide. This study aimed to determine rates and predictors of survival among Omani patients with CHC at a tertiary hospital in Muscat, Oman. Methods: This ambidirectional cohort study included all CHC patients who presented to the Sultan Qaboos University Hospital between January 2009 and December 2017. Baseline demographic, clinical, laboratory, and radiological data were analyzed. Patients were followed-up until death or the endpoint of the study (April 2022) to determine survival and associations with other parameters. Results: A total of 702 CHC patients were included, of which 398 (56.7%) were under 50 years of age and 477 (67.9%) were male. Overall, 180 patients (25.6%) died by the study endpoint. The mean duration of follow-up was 93.3 ± 48.0 months. The 5-year survival rate was estimated to be 80.5%, while the 10-year survival was 73%. Sustained virological response and the absence of diabetes mellitus, chronic kidney disease, HCC, or other malignancies were associated with significantly better overall survival. The 3- and 5-year survival rate of patients with hepatitis C virus (HCV)-related HCC was 46.5% and 27.6%, respectively, with a median survival of 29.5 months. Co-infection with hepatitis B was associated with poor survival among this subgroup; conversely, early HCV screening and the presence of a single HCC lesion were associated with better overall survival. Conclusions: National policies for early CHC screening and rapid treatment are needed to improve survival rates in this population.
背景:慢性丙型肝炎(CHC)是世界范围内肝硬化和肝细胞癌(HCC)的主要病因。本研究旨在确定阿曼马斯喀特一家三级医院的阿曼CHC患者的生存率和预测因素。方法:这项双向队列研究纳入了2009年1月至2017年12月期间在苏丹卡布斯大学医院就诊的所有CHC患者。对基线人口统计学、临床、实验室和放射学数据进行分析。对患者进行随访,直至死亡或研究终点(2022年4月),以确定生存率及其与其他参数的关联。结果:共纳入702例CHC患者,其中50岁以下398例(56.7%),男性477例(67.9%)。总体而言,180名患者(25.6%)在研究终点死亡。平均随访时间93.3±48.0个月。5年生存率为80.5%,10年生存率为73%。持续的病毒学应答和无糖尿病、慢性肾病、肝细胞癌或其他恶性肿瘤与较好的总生存率显著相关。丙型肝炎病毒(HCV)相关HCC患者的3年和5年生存率分别为46.5%和27.6%,中位生存期为29.5个月。在该亚组中,合并感染乙型肝炎与较差的生存率相关;相反,早期HCV筛查和单个HCC病变的存在与更好的总生存率相关。结论:需要制定早期CHC筛查和快速治疗的国家政策来提高这一人群的生存率。
{"title":"Predictors of survival among patients with chronic hepatitis C at a tertiary care center in Oman","authors":"Halima H. Al-Shuaili, Said A. Al-Busafi, Khalid Al-Naamani, Zakariya Al-Naamani","doi":"10.4103/sjg.sjg_201_23","DOIUrl":"https://doi.org/10.4103/sjg.sjg_201_23","url":null,"abstract":"Abstract Background: Chronic hepatitis C (CHC) is a leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide. This study aimed to determine rates and predictors of survival among Omani patients with CHC at a tertiary hospital in Muscat, Oman. Methods: This ambidirectional cohort study included all CHC patients who presented to the Sultan Qaboos University Hospital between January 2009 and December 2017. Baseline demographic, clinical, laboratory, and radiological data were analyzed. Patients were followed-up until death or the endpoint of the study (April 2022) to determine survival and associations with other parameters. Results: A total of 702 CHC patients were included, of which 398 (56.7%) were under 50 years of age and 477 (67.9%) were male. Overall, 180 patients (25.6%) died by the study endpoint. The mean duration of follow-up was 93.3 ± 48.0 months. The 5-year survival rate was estimated to be 80.5%, while the 10-year survival was 73%. Sustained virological response and the absence of diabetes mellitus, chronic kidney disease, HCC, or other malignancies were associated with significantly better overall survival. The 3- and 5-year survival rate of patients with hepatitis C virus (HCV)-related HCC was 46.5% and 27.6%, respectively, with a median survival of 29.5 months. Co-infection with hepatitis B was associated with poor survival among this subgroup; conversely, early HCV screening and the presence of a single HCC lesion were associated with better overall survival. Conclusions: National policies for early CHC screening and rapid treatment are needed to improve survival rates in this population.","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136265927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in endoscopy: Overview, applications, and future directions. 内窥镜检查中的人工智能:概述、应用和未来方向。
IF 2.7 4区 医学 Q2 Medicine Pub Date : 2023-09-06 DOI: 10.4103/sjg.sjg_286_23
Arif A Arif, Shirley X Jiang, Michael F Byrne

Since the emergence of artificial intelligence (AI) in medicine, endoscopy applications in gastroenterology have been at the forefront of innovations. The ever-increasing number of studies necessitates the need to organize and classify applications in a useful way. Separating AI capabilities by computer aided detection (CADe), diagnosis (CADx), and quality assessment (CADq) allows for a systematic evaluation of each application. CADe studies have shown promise in accurate detection of esophageal, gastric and colonic neoplasia as well as identifying sources of bleeding and Crohn's disease in the small bowel. While more advanced CADx applications employ optical biopsies to give further information to characterize neoplasia and grade inflammatory disease, diverse CADq applications ensure quality and increase the efficiency of procedures. Future applications show promise in advanced therapeutic modalities and integrated systems that provide multimodal capabilities. AI is set to revolutionize clinical decision making and performance of endoscopy.

自从人工智能在医学中出现以来,内窥镜检查在胃肠病学中的应用一直处于创新的前沿。研究的数量不断增加,需要以有用的方式对应用程序进行组织和分类。通过计算机辅助检测(CADe)、诊断(CADx)和质量评估(CADq)分离人工智能功能,可以对每个应用程序进行系统评估。CADe研究在准确检测食道、胃和结肠肿瘤以及确定小肠出血和克罗恩病的来源方面显示出了前景。虽然更先进的CADx应用程序使用光学活检来提供进一步的信息来表征肿瘤形成和分级炎症性疾病,但不同的CADq应用程序可以确保质量并提高手术效率。未来的应用在提供多模式能力的先进治疗模式和集成系统方面显示出前景。人工智能将彻底改变内窥镜检查的临床决策和性能。
{"title":"Artificial intelligence in endoscopy: Overview, applications, and future directions.","authors":"Arif A Arif,&nbsp;Shirley X Jiang,&nbsp;Michael F Byrne","doi":"10.4103/sjg.sjg_286_23","DOIUrl":"https://doi.org/10.4103/sjg.sjg_286_23","url":null,"abstract":"<p><p>Since the emergence of artificial intelligence (AI) in medicine, endoscopy applications in gastroenterology have been at the forefront of innovations. The ever-increasing number of studies necessitates the need to organize and classify applications in a useful way. Separating AI capabilities by computer aided detection (CADe), diagnosis (CADx), and quality assessment (CADq) allows for a systematic evaluation of each application. CADe studies have shown promise in accurate detection of esophageal, gastric and colonic neoplasia as well as identifying sources of bleeding and Crohn's disease in the small bowel. While more advanced CADx applications employ optical biopsies to give further information to characterize neoplasia and grade inflammatory disease, diverse CADq applications ensure quality and increase the efficiency of procedures. Future applications show promise in advanced therapeutic modalities and integrated systems that provide multimodal capabilities. AI is set to revolutionize clinical decision making and performance of endoscopy.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41155391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CRAB score for prediction of colectomy within 2 years following admission for acute severe ulcerative colitis. CRAB评分预测急性严重溃疡性结肠炎入院后2年内结肠切除术。
IF 2.7 4区 医学 Q2 Medicine Pub Date : 2023-09-01 DOI: 10.4103/sjg.sjg_521_22
Krishnadas Devadas, Suprabhat Giri, Jijo Varghese, Antony George

Background: The Oxford and Swedish indexes were developed to predict in-hospital colectomy in acute severe ulcerative colitis (ASUC), but not long-term prediction, and all these indexes were based on Western data. Our study aimed to analyze the predictors of colectomy within 3 years of ASUC in an Indian cohort and derive a simple predictive score.

Methods: A prospective observational study was conducted in a tertiary health care center in South India over a period of 5 years. All patients admitted with ASUC were followed up for a period of 24 months after the index admission, to look for progression to colectomy.

Results: A total of 81 (47 male) patients were included in the derivation cohort. Fifteen (18.5%) patients required colectomy during a follow-up period of 24 months. On regression analysis, C-reactive protein (CRP) and serum albumin were independent predictors of 24-month colectomy. The CRAB (CRP + AlBumin) score was obtained by multiplying coefficient of beta to albumin and CRP (CRAB score = CRP x 0.2 - Albumin x 0.26). The CRAB score demonstrated an AUROC of 0.923 and a score of >0.4 with a sensitivity of 82% and specificity of 92% for the prediction of 2-year colectomy following ASUC. The score was validated in a validation cohort of 31 patients, and at >0.4, the score had a sensitivity of 83% and a specificity of 96% in predicting colectomy.

Conclusion: CRAB score is a simple prognostic score that can predict 2-year colectomy in ASUC patients with high sensitivity and specificity.

背景:牛津和瑞典的指数是为了预测急性严重溃疡性结肠炎(ASUC)的住院结肠切除术,而不是长期预测,所有这些指数都是基于西方数据。我们的研究旨在分析印度队列中ASUC 3年内结肠切除术的预测因素,并得出一个简单的预测分数。方法:在南印度的一家三级医疗保健中心进行为期5年的前瞻性观察性研究。所有入住ASUC的患者在指数入院后随访24个月,以寻找结肠切除术的进展。结果:共有81名(47名男性)患者被纳入衍生队列。在24个月的随访期内,15名(18.5%)患者需要结肠切除术。回归分析显示,C反应蛋白(CRP)和血清白蛋白是24个月结肠切除术的独立预测因素。CRAB(CRP+AlBumin)评分是通过将β与白蛋白和CRP的系数相乘获得的(CRAB评分=CRP x 0.2-白蛋白x 0.26)。CRAB评分显示AUROC为0.923,评分>0.4,预测ASUC后2年结肠切除术的敏感性为82%,特异性为92%。该评分在一个由31名患者组成的验证队列中进行了验证,在>0.4时,该评分在预测结肠切除术方面的敏感性为83%,特异性为96%。结论:CRAB评分是一种简单的预后评分,可预测ASUC患者2年结肠切除术,具有较高的敏感性和特异性。
{"title":"CRAB score for prediction of colectomy within 2 years following admission for acute severe ulcerative colitis.","authors":"Krishnadas Devadas, Suprabhat Giri, Jijo Varghese, Antony George","doi":"10.4103/sjg.sjg_521_22","DOIUrl":"10.4103/sjg.sjg_521_22","url":null,"abstract":"<p><strong>Background: </strong>The Oxford and Swedish indexes were developed to predict in-hospital colectomy in acute severe ulcerative colitis (ASUC), but not long-term prediction, and all these indexes were based on Western data. Our study aimed to analyze the predictors of colectomy within 3 years of ASUC in an Indian cohort and derive a simple predictive score.</p><p><strong>Methods: </strong>A prospective observational study was conducted in a tertiary health care center in South India over a period of 5 years. All patients admitted with ASUC were followed up for a period of 24 months after the index admission, to look for progression to colectomy.</p><p><strong>Results: </strong>A total of 81 (47 male) patients were included in the derivation cohort. Fifteen (18.5%) patients required colectomy during a follow-up period of 24 months. On regression analysis, C-reactive protein (CRP) and serum albumin were independent predictors of 24-month colectomy. The CRAB (CRP + AlBumin) score was obtained by multiplying coefficient of beta to albumin and CRP (CRAB score = CRP x 0.2 - Albumin x 0.26). The CRAB score demonstrated an AUROC of 0.923 and a score of >0.4 with a sensitivity of 82% and specificity of 92% for the prediction of 2-year colectomy following ASUC. The score was validated in a validation cohort of 31 patients, and at >0.4, the score had a sensitivity of 83% and a specificity of 96% in predicting colectomy.</p><p><strong>Conclusion: </strong>CRAB score is a simple prognostic score that can predict 2-year colectomy in ASUC patients with high sensitivity and specificity.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9267257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Saudi Journal of Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1